Healthcare sector | Medical Devices industry
| Price | $1.86 |
|---|---|
| Shares Outstanding | 63.72M |
| All-Time Low | $1.86 |
| 52-Week Low | $1.82 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $0.48 |
| Net Tangible Assets / Share | $1.08 |
| Shares Outstanding Ave Change (Annual) | 4.8% |
| Shares Δ YoY | 0.99% |
| Avg CA Burn (Annual %) | 8.92% (as of 2-20-2026) |
| Avg CA Burn (Quarterly %) | -3.19% (as of 2-20-2026) |
| Max Earning Power / Share | $-1.82 |
|---|---|
| Adjusted Earning Power |
$-2.43
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
2.08%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 2-20-2026) |
| Avg EBITDA (5Q) | 610K (as of 2-20-2026) |
| Avg Net Income (5Y) | -42.2M (as of 2-20-2026) |
| Avg Net Income (5Q) | -13.1M (as of 2-20-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 2-20-2026 |
| Consecutive Years Paid | No | 2-20-2026 |
| Pays Dividend | No | 2-20-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 2-20-2026 |
| Net Income Positive | No | 2-20-2026 |
| Current Dividend Streak | No | 2-20-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-09-30 | Quarterly | $1.08 | 69M ($69,010,000) | 63.7M (63,704,810) |
| 2025-06-30 | Quarterly | $1.22 | 77.2M ($77,200,000) | 63M (63,042,314) |
| 2025-03-31 | Quarterly | $1.35 | 84.7M ($84,689,000) | 62.9M (62,891,506) |
| 2024-12-31 | Quarterly | $1.48 | 92M ($92,002,000) | 62.4M (62,361,710) |
| 2024-12-31 | Annual | $1.48 | 92M ($92,002,000) | 62.4M (62,361,710) |
| 2024-09-30 | Quarterly | $1.35 | 83.8M ($83,779,000) | 62.3M (62,275,371) |
| 2023-12-31 | Annual | $1.88 | 116.1M ($116,098,000) | 61.7M (61,748,436) |
| 2022-12-31 | Annual | $1.09 | 60.5M ($60,529,000) | 55.6M (55,628,208) |
| 2021-12-31 | Annual | $1.72 | 93.1M ($93,073,000) | 54.2M (54,181,082) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 209.4M ($209,357,000) |
| 2023-12-31 | 187.1M ($187,118,000) |
| 2022-12-31 | 141.8M ($141,838,000) |
| 2021-12-31 | 94.4M ($94,419,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| No recent share changes | ||
Latest short-interest change: 3,558,929 shares (7.34% of float) | Days to cover: 5.61
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-02-27 | 3,558,929 shares | +315,417 | +9.72% |
| 2026-02-11 | 3,243,512 shares | +235,919 | +7.84% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.